Hepavir: The first observational study of patients treated with alpha 2-a interferon for chronic hepatitis C: Evaluation of asthenia and its social consequences;Hépavir, première étude observationnelle d'une cohorte de malades traités par interféron alpha-2a en monothérapie

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 12, 2001, Pages 1061-1066

  Roudot Thoraval, Françoise ^a,e   Abergel, Armand ^a   Allaert, François ^b   Bourliere, Marc ^a   Desmorat, Hervé ^a   Fagnani, Francis ^a   Fontanges, Thierry ^a   Hanana, Ahmed ^a   Pol, Stanislas ^a   Zarski, Jean Pierre ^a   Rousseaux, Chantal ^c   Gandossi, Corinne ^d   Abelsour, Laurence ^d   Dole, Sylvie ^d   Dantin, Sylvie ^d   Eberle, Frédéric ^d   Saint Marc Girardin, Marie France ^d  

^a Comité Scientifique Hépavir ^*  (France)

^b Cen Biotech   (France)

^c Agence Nukleus   (France)

^d Roche   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

Absence from work; Fatigue; Hepatitis C; Interferon; Observational study

Indexed keywords

ALPHA2A INTERFERON; HEPAVIR;

ABSENTEEISM; ADULT; ARTICLE; ASTHENIA; ECONOMIC ASPECT; FATIGUE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT MONITORING; RATING SCALE; SELF EVALUATION; SELF INJECTION; SOCIAL ASPECT;

ABSENTEEISM; ADULT; ANTIVIRAL AGENTS; ASTHENIA; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED;

EID: 0035695697     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C
2. Comparative efficacy of interferon alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis
3. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose
4. Factors affecting treatment responses to interferon-α in chronic hepatitis C
5. A comparison of observational studies and randomized, controlled trials
6. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
7. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
8. Mesure de la qualité de vie chez les malades ayant une hépatite chronique C: Validation d'un indicateur général et d'un indicateur spécifique
9. Epidémiologie de l'infection virale C chez 1304 sujets VHC positif. Variations en fonction du mode de contamination et de I'année du diagnostic
10. Hepatitis C virus genotypes in France: Relationship with epidemiology, pathogenicity and response to interferon therapy
11. Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response
12. The impact of diagnosis of hepatitis C virus on quality of life
13. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients
14. Impaired health-related quality of life in chronic hepatitis C: The how, but not the why
15. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C
16. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity